Article
A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing
2020-07-03
Abstract excerpt
Extensive testing is essential to break the transmission of the new coronavirus SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Recently, CRISPR-based diagnostics have emerged as attractive alternatives to quantitative real-time PCR due to their faster turnaround time and their potential to be used in point-of-care testing scenarios. However, existing CRISPR-based assays for COVID-19 have not considered vi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7cd3a5ba-92d8-55b2-a69d-6c3c64ad5036
- DOI
- 10.1101/2020.07.03.185850
